Airway Mucus Hypersecretion in Asthma and COPD: Not the Same?

Asthma and COPD

Volumn , Issue , 2009, Pages 211-223

  Rogers, Duncan F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882896232     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374001-4.00017-1     Document Type: Chapter

References (120)

1. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965, i:775-779. Medical Research Council.
2. Openshaw PJ, Turner-Warwick M Observations on sputum production in patients with variable airflow obstruction; implications for the diagnosis of asthma and chronic bronchitis. Respir Med 1989, 83:25-31.
3. Aikawa T, Shimura S, Sasaki H, Takishima T, Yaegashi H, Takahashi T Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140:477-482.
4. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992, 101:916-921.
5. Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, Hotchkiss JA, Zhang Y, Novikov A, Dolganov G, Fahy JV Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001, 163:517-523.
6. Reid L Pathology of chronic bronchitis. Lancet 1954, i:275-278.
7. Vestbo J Epidemiological studies in mucus hypersecretion. Novartis Found Symp 2002, 248:3-12.
8. Rogers DF Airway mucus hypersecretion in asthma: An undervalued pathology?. Curr Opin Pharmacol 2004, 4:241-250.
9. Turner-Warwick M, Openshaw P Sputum in asthma. Postgrad Med J 1987, 63(Suppl 1):79-82.
10. Global Initiative for Asthma. Global strategy for asthma management and prevention., 2006. http://www.ginasthma.org.
11. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease., 2006. http://www.goldcopd.org.
12. Rogers DF, Barnes PJ Treatment of airway mucus hypersecretion. Ann Med 2006, 38:116-125.
13. Lethem MI, James SL, Marriott C, Burke JF The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990, 3:19-23.
14. Shah SA, Santago P, Rubin BK Quantification of biopolymer filament structure. Ultramicroscopy 2005, 104:244-254.
15. Tomkiewicz RP, Kishioka C, Freeman J, Rubin BK DNA and actin filament ultrastructure in cystic fibrosis sputum. Cila, Mucus and Mucociliary Interactions 1998, 333-341. Marcel Dekker, New York. G. Baum (Ed.).
16. Knowles MR, Boucher RC Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002, 109:571-577.
17. Morgenroth K, Bolz J Morphological features of the interaction between mucus and surfactant on the bronchial mucosa. Respiration 1985, 47:225-231.
18. Rose MC, Voynow JA Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006, 86:245-278.
19. King M Experimental models for studying mucociliary clearance. Eur Respir J 1998, 11:222-228.
20. King M Physiology of mucus clearance. Paediatr Respir Rev 2006, 7(Suppl 1):S212-S214.
21. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M Regulation of mucociliary clearance in health and disease. Eur Respir J 1999, 13:1177-1188.
22. Sleigh MA, Blake JR, Liron N The propulsion of mucus by cilia. Am Rev Respir Dis 1988, 137:726-741.
23. Davies JR, Herrmann A, Russell W, Svitacheva N, Wickström C, Carlstedt I Respiratory tract mucins: Structure and expression patterns. Mucus Hypersecretion in Respiratory Disease 2002, 76-88. John Wiley & Sons, Chichester.
24. Rogers DF Airway goblet cell hyperplasia in asthma: Hypersecretory and anti-inflammatory?. Clin Exp Allergy 2002, 32:1124-1127.
25. Finkbeiner WE Physiology and pathology of tracheobronchial glands. Respir Physiol 1999, 118:77-83.
26. Thornton DJ, Rousseau K, McGuckin MA Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 2008.
27. Hanisch FG O-glycosylation of the mucin type. Biol Chem 2001, 382:143-149.
28. Dell A, Morris HR Glycoprotein structure determination by mass spectrometry. Science 2001, 291:2351-2356.
29. Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK Structural organization and classification of the human mucin genes. Front Biosci 2001, 6:D1192-D1206.
30. Sheehan JK, Thornton DJ, Somerville M, Carlstedt I Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins. Am Rev Respir Dis 1991, 144:S4-S9.
31. Thornton DJ, Davies JR, Kraayenbrink M, Richardson PS, Sheehan JK, Carlstedt I Mucus glycoproteins from "normal" human tracheobronchial secretion. Biochem J 1990, 265:179-186.
32. Thornton DJ, Devine PL, Hanski C, Howard M, Sheehan JK Identification of two major populations of mucins in respiratory secretions. Am J Respir Crit Care Med 1994, 150:823-832.
33. Thornton DJ, Sheehan JK, Carlstedt I Heterogeneity of mucus glycoproteins from cystic fibrotic sputum. Are there different families of mucins?. Biochem J 1991, 276:677-682.
34. Hovenberg HW, Davies JR, Carlstedt I Different mucins are produced by the surface epithelium and the submucosa in human trachea: Identification of MUC5AC as a major mucin from the goblet cells. Biochem J 1996, 318:319-324.
35. Hovenberg HW, Davies JR, Herrmann A, Linden CJ, Carlstedt I MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996, 13:839-847.
36. Sheehan JK, Howard M, Richardson PS, Longwill T, Thornton DJ Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem J 1999, 338:507-513.
37. Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK Respiratory mucins: Identification of core proteins and glycoforms. Biochem J 1996, 316:967-975.
38. Thornton DJ, Howard M, Khan N, Sheehan JK Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J Biol Chem 1997, 272:9561-9566.
39. Wickstrom C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: Identification of glycoforms and C-terminal cleavage. Biochem J 1998, 334:685-693.
40. Guyonnet DV, Audie JP, Debailleul V, Laine A, Buisine MP, Galiegue-Zouitina S, Pigny P, Degand P, Aubert JP, Porchet N Characterization of the human mucin gene MUC5AC: A consensus cysteine-rich domain for 11p15 mucin genes?. Biochem J 1995, 305:211-219.
41. Sheehan JK, Richardson PS, Fung DC, Howard M, Thornton DJ Analysis of respiratory mucus glycoproteins in asthma: A detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995, 13:748-756.
42. Rose MC, Nickola TJ, Voynow JA Airway mucus obstruction: Mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol 2001, 25:533-537.
43. Desseyn JL, Buisine MP, Porchet N, Aubert JP, Laine A Genomic organization of the human mucin gene MUC5B. cDNA and genomic sequences upstream of the large central exon. J Biol Chem 1998, 273:30157-30164.
44. Sharma P, Dudus L, Nielsen PA, Clausen H, Yankaskas JR, Hollingsworth MA, Engelhardt JF MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 1998, 19:30-37.
45. Audie JP, Janin A, Porchet N, Copin MC, Gosselin B, Aubert JP Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem 1993, 41:1479-1485.
46. Reid CJ, Gould S, Harris A Developmental expression of mucin genes in the human respiratory tract. Am J Respir Cell Mol Biol 1997, 17:592-598.
47. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ Heterogeneity of airways mucus: Variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002, 361:537-546.
48. Steiger D, Fahy J, Boushey H, Finkbeiner WE, Basbaum C Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. Am J Respir Cell Mol Biol 1994, 10:538-545.
49. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A, Fabbri LM Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000, 161:1016-1021.
50. Mullen JB, Wright JL, Wiggs BR, Pare PD, Hogg JC Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: Relationship to lung function. Thorax 1987, 42:843-848.
51. Reid L Measurement of the bronchial mucous gland layer: A diagnostic yardstick in chronic bronchitis. Thorax 1960, 15:132-141.
52. Restrepo G, Heard BE The size of the bronchial glands in chronic bronchitis. J Pathol Bacteriol 1963, 85:305-310.
53. Wanner A Clinical aspects of mucociliary transport. Am Rev Respir Dis 1977, 116:73-125.
54. McDowell EM, Barrett LA, Harris CC, Trump BF Abnormal cilia in human bronchial epithelium. Arch Pathol Lab Med 1976, 100:429-436.
55. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987, 136:225-244. American Thoracic Society.
56. The British guidelines on asthma management. Thorax 1997, 52(Suppl 1):S1-S21. British Thoracic Society.
57. Eapen SS, Busse WW Asthma. Clin Allergy Immunol 2002, 16:325-353.
58. Dunnill MS The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960, 13:27-33.
59. Houston JC, De Navasquez S, Trounce JR A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953, 8:207-213.
60. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991, 143:138-143.
61. Bhaskar KR, O'Sullivan DD, Coles SJ, Kozakewich H, Vawter GP, Reid LM Characterization of airway mucus from a fatal case of status asthmaticus. Pediatr Pulmonol 1988, 5:176-182.
62. Dunnill MS The morphology of the airways in bronchial asthma. New Directions in Asthma 1975, 213-221. American College of Physicians, Park Ridge. M. Stein (Ed.).
63. Fahy JV, Liu J, Wong H, Boushey HA Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993, 147:1126-1131.
64. Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993, 147:1132-1137.
65. Lopez-Vidriero MT, Reid L Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am Rev Respir Dis 1978, 117:465-477.
66. Lopez-Vidriero MT, Reid L Bronchial mucus in health and disease. Br Med Bull 1978, 34:63-74.
67. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
68. Beasley R, Roche WR, Roberts JA, Holgate ST Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989, 139:806-817.
69. Carson JL, Collier AM, Fernald GW, Hu SC Microtubular discontinuities as acquired ciliary defects in airway epithelium of patients with chronic respiratory diseases. Ultrastruct Pathol 1994, 18:327-332.
70. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985, 131:599-606.
71. Gleich GJ, Loegering DA, Frigas E, Filley WV The eosinophil granule major basic protein: Biological activities and relationship to bronchial asthma. Monogr Allergy 1983, 18:277-283.
72. Del Donno M, Bittesnich D, Chetta A, Olivieri D, Lopez-Vidriero MT The effect of inflammation on mucociliary clearance in asthma: An overview. Chest 2000, 118:1142-1149.
73. Wanner A, Salathe M, O'Riordan TG Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996, 154:1868-1902.
74. Clarke SW, Pavia D Lung mucus production and mucociliary clearance: Methods of assessment. Br J Clin Pharmacol 1980, 9:537-546.
75. Pavia D, Sutton PP, Agnew JE, Lopez-Vidriero MT, Newman SP, Clarke SW Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl 1983, 127:41-56.
76. Moretti M, Lopez-Vidriero MT, Pavia D, Clarke SW Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis. Thorax 1997, 52:176-180.
77. Goodman RM, Yergin BM, Landa JF, Golivanux MH, Sackner MA Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. Am Rev Respir Dis 1978, 117:205-214.
78. Agnew JE, Little F, Pavia D, Clarke SW Mucus clearance from the airways in chronic bronchitis - Smokers and ex-smokers. Bull Eur Physiopathol Respir 1982, 18:473-484.
79. van der Schans CP, Piers DA, Beekhuis H, Koeter GH, van der Mark TW, Postma DS Effect of forced expirations on mucus clearance in patients with chronic airflow obstruction: Effect of lung recoil pressure. Thorax 1990, 45:623-627.
80. Ericsson CH, Svartengren K, Svartengren M, Mossberg B, Philipson K, Blomquist M, Camner P Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. Eur Respir J 1995, 8:1886-1893.
81. Pavia D, Bateman JR, Sheahan NF, Agnew JE, Clarke SW Tracheobronchial mucociliary clearance in asthma: Impairment during remission. Thorax 1985, 40:171-175.
82. Bateman JR, Pavia D, Sheahan NF, Agnew JE, Clarke SW Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax 1983, 38:463-467.
83. Foster WM, Langenback EG, Bergofsky EH Lung mucociliary function in man: Interdependence of bronchial and tracheal mucus transport velocities with lung clearance in bronchial asthma and healthy subjects. Ann Occup Hyg 1982, 26:227-244.
84. Messina MS, O'Riordan TG, Smaldone GC Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 1991, 143:993-997.
85. Bateman JR, Pavia D, Clarke SW The retention of lung secretions during the night in normal subjects. Clin Sci Mol Med Suppl 1978, 55:523-527.
86. Pavia D, Lopez-Vidriero MT, Clarke SW Mediators and mucociliary clearance in asthma. Bull Eur Physiopathol Respir 1987, 23(Suppl 10):89s-94s.
87. Rogers DF In vivo preclinical test models for studying airway mucus secretion. Pulm Pharmacol Ther 1997, 10:121-128.
88. Ayers MM, Jeffery PK Proliferation and differentiation in mammalian airway epithelium. Eur Respir J 1988, 1:58-80.
89. Nadel JA, Burgel PR The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 2001, 1:254-258.
90. Rogers DF Airway goblet cells: Responsive and adaptable front-line defenders. Eur Respir J 1994, 7:1690-1706.
91. Rogers AV, Dewar A, Corrin B, Jeffery PK Identification of serous-like cells in the surface epithelium of human bronchioles. Eur Respir J 1993, 6:498-504.
92. Basbaum CB, Jany B, Finkbeiner WE The serous cell. Annu Rev Physiol 1990, 52:97-113.
93. Singh G, Katyal SL Clara cell proteins. Ann NY Acad Sci 2000, 923:43-58.
94. Djukanovic R Airway inflammation in asthma and its consequences: Implications for treatment in children and adults. J Allergy Clin Immunol 2002, 109:S539-S548.
95. Jeffery PK Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999, 29(Suppl 2):14-26.
96. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1304-1309.
97. Barnes PJ New treatments for COPD. Nat Rev Drug Discov 2002, 1:437-446.
98. Barnes PJ, Chung KF, Page CP Inflammatory mediators of asthma: An update. Pharmacol Rev 1998, 50:515-596.
99. Charman J, Reid L Sputum viscosity in chronic bronchitis, bronchiectasis, asthma and cystic fibrosis. Biorheology 1972, 9:185-199.
100. Shimura S, Sasaki T, Sasaki H, Takishima T, Umeya K Viscoelastic properties of bronchorrhoea sputum in bronchial asthmatics. Biorheology 1988, 25:173-179.
101. Rogers DF Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care 2007, 52:1134-1146.
102. Rogers DF, Evans TW Plasma exudation and oedema in asthma. Br Med Bull 1992, 48:120-134.
103. Shimura S, Andoh Y, Haraguchi M, Shirato K Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996, 9:1395-1401.
104. Chen Y, Zhao YH, Di YP, Wu R Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5'-flanking region. Am J Respir Cell Mol Biol 2001, 25:542-553.
105. Davies JR, Carlstedt I Respiratory tract mucins. Cilia and Mucus: From Development to Respiratory Defense 2001, 167-178. Marcel Dekker Inc., New York. M. Salathe (Ed.).
106. Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, Roberts P, McCann B, Nicholson AG, Harrison BD, Chung KF Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002, 40:367-373.
107. Groneberg DA, Eynott PR, Oates T, Lim S, Wu R, Carlstedt I, Nicholson AG, Chung KF Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med 2002, 96:81-86.
108. Davies JR, Svitacheva N, Lannefors L, Kornfalt R, Carlstedt I Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions. Biochem J 1999, 344(Pt 2):321-330.
109. Glynn AA, Michaels L Bronchial biopsy in chronic bronchitis and asthma. Thorax 1960, 15:142-153.
110. Rogers DF The role of airway secretions in COPD: Pathophysiology, epidemiology and pharmacotherapeutic options. COPD 2005, 2:341-353.
111. Burgel PR, Nadel JA Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004, 59:992-996.
112. Hewson CA, Edbrooke MR, Johnston SL PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 2004, 344:683-695.
113. Toda M, Tulic MK, Levitt RC, Hamid Q A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 2002, 109:246-250.
114. Zhou Y, Shapiro M, Dong Q, Louahed J, Weiss C, Wan S, Chen Q, Dragwa C, Savio D, Huang M, Fuller C, Tomer Y, Nicolaides NC, McLane M, Levitt R A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Mucus Hypersecretion in Respiratory Disease 2002, 150-165. Wiley, Chichester.
115. Donnelly LE, Rogers DF Antiproteases and retinoids for treatment of chronic obstructive pulmonary disease. Expert Opin Ther Patents 2003, 13:1345-1372.
116. Li Y, Martin LD, Spizz G, Adler KB MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 2001, 276:40982-40990.
117. Singer M, Martin LD, Vargaftig BB, Park J, Gruber AD, Li Y, Adler KB A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004, 10:193-196.
118. Foster KA A new wrinkle on pain relief: Re-engineering clostridial neurotoxins for analgesics. Drug Discov Today 2005, 10:563-569.
119. Foster KA, Adams EJ, Durose L, Cruttwell CJ, Marks E, Shone CC, Chaddock JA, Cox CL, Heaton C, Sutton JM, Wayne J, Alexander FC, Rogers DF Re-engineering the target specificity of clostridial neurotoxins - a route to novel therapeutics. Neurotox Res 2006, 9:101-107.
120. Adams EJ, Foster K, Barnes PJ, Rogers DF Inhibition of airway mucin secretion by a retargeted clostridial endopeptidase in a rat model of COPD. Am J Respir Crit Care Med 2008, (abstracts issue) (in press).